Pharmhouse Corp (PHSE) Financials

$0.02

$-0.01 (-29.65%)

As on 04-Sep-2026 13:38EDT

Market cap

$46 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Operating Revenue	6.60	3.02	--	--	--	--
Cost of Revenue	1.54	0.67	--	--	--	0.12
Gross Profit	5.06	2.35	--	--	--	-0.12
Operating Expenses	17.25	11.44	0.46	0.52	0.26	0.23
Operating Profit (EBIT)	-12.19	-9.09	-0.46	-0.52	-0.26	-0.34
Other Income	--	--	--	--	--	--
Profit before Tax	-12.61	-9.10	-0.78	-2.50	-2.95	-0.34
Provision for Tax	--	--	--	-0.17	--	--
Profit after Tax (Net Income)	-12.93	-9.42	-0.78	-2.33	-2.95	-0.34
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Shareholder's Funds	46.40	52.30	-1.00	-0.24	3.52	6.47
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.17	0.17	0.17	--	--	--
Current Liabilities	7.25	7.87	1.72	0.36	0.39	0.13
Total Liabilities	61.07	60.35	0.71	0.12	3.92	6.60

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Non-Current Assets	50.01	50.14	0.35	--	0.72	0.72
Current Assets	3.81	10.20	0.37	0.12	3.19	5.88
Total Assets	57.63	60.35	0.71	0.12	3.92	6.60
Total Debt*	4.71	4.89	1.42	0.35	0.11	--
Net Current Assets	--	2.33	-1.11	--	--	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Cash From Operating Activities	--	-2.49	-0.61	1.71	--	-0.07
Cash Flow from Investing Activities	--	0.01	-0.35	--	--	0.00
Cash from Financing Activities	--	1.46	1.21	-1.59	--	0.04
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Adjusted EPS ($)	-0.01	-0.01	0.00	-0.01	-0.03	0.00
Cash EPS ($)	--	-0.01	0.00	-0.01	-0.03	0.00
Adjusted Book Value ($)	--	0.03	--	--	0.04	0.07
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.00	0.00	0.01	--	0.00
Free Cash Flow per Share ($)	--	0.00	0.00	0.01	--	0.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
ROCE (%)	--	-32.70	-291.40	-124.43	-58.42	-5.37
ROE (%)	-26.19	-36.73	125.29	-141.84	-59.06	-5.37
ROA (%)	-44.52	-30.85	-185.74	-115.38	-56.12	-5.21
EBIT Margin (%)	-55.58	--	--	--	--	--
Net Margin (%)	-195.91	-312.04	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	21.89	-407.73	89.67
Net Profit Growth (%)	-558.18	-1,112.21	66.66	21.06	-756.62	93.64
EPS Growth (%)	-232.55	-5.74	0.92	0.64	-7.57	0.96
Book Value Growth (%)	843.86	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Price / Earnings	--	-19.49	-8.88	-0.32	-0.05	-13.62
Price / Book Value	0.99	3.51	-6.87	-3.16	0.04	0.73
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-20.71	-14.06	-0.46	-0.09	-13.62
Close Price ($)	0.07	0.12	0.01	0.00	0.00	0.05
High Price ($)	0.20	0.20	0.02	0.04	0.06	0.95
Low Price ($)	0.03	0.00	0.00	0.00	0.00	0.05
Market Cap ($ Cr)	46.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Debt to Equity	--	0.09	-1.42	-1.48	0.03	--
Short term debt to equity ratio	0.10	0.09	-1.42	-1.48	0.03	--
Current Ratio	0.53	1.30	0.21	0.34	8.10	45.78
Quick Ratio	0.51	1.28	0.21	--	--	--
Interest Coverage	-60.18	--	--	-16.15	-2,195.64	--

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-15
Debtors to sales (%)	3.70	10.81	--	--	--	--
Asset Turnover	0.23	0.10	--	--	--	--
Receivable days	--	19.75	--	--	--	--
Inventory Days	--	34.86	--	--	--	18,452.08
Payable days	--	253.06	--	--	--	627.01
Cash Conversion Cycle	--	-198.45	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.